Ukraine Increases Focus On Implementing EU Pharmaceutical Standards

Ukraine | Pharmaceuticals & Healthcare | Mon Nov 11, 2013

News: Unification of Ukrainian regulations for medicines and medical devices with the EU guidelines remains an important of concern for the country's pharmaceutical sector, according to Oleksiy Solovyov, the chairman of the State Service of Ukraine on Drugs. Ukraine has progressed considerably in the last few years in implementing international pharmaceutical standards through the introduction of two important global pharmaceutical quality standards - the Good Manufacturing Practice (GMP) and the Good Pharmacy Practice (GPP), according to experts. The country's pharmaceutical industry needs an investment of up to US$1bn for adopting the international quality standards, experts added.

Access all of our latest analysis, data and forecasts - request a trial

Related Articles

The Ukrainian prime minister has signalled his intent to reform the healthcare sector and pharmaceutical legislatio...The Ukrainian prime minister has signalled his intent to reform the healthcare sector and pharmaceutical legislation that will be of benefit to the pharmaceutical and hea...

The reform agenda set out by the health ministry will be positive for Ukraine's pharmaceutical and healthcare secto...The reform agenda set out by the health ministry will be positive for Ukraine's pharmaceutical and healthcare sector over the long term. National health insurance and pha...

Hospital sales in Ukraine saw a significant decline as the acute political and economic situation forced cancellati...Hospital sales in Ukraine saw a significant decline as the acute political and economic situation forced cancellations and delays to government procurement. A revision of...

Related White Papers

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital...Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks pr...